7NCCN Non-small cell lung cancer[EB/OL].Practice Guidelines in Oncology-v.2.2005.
8Brundage MD,Davies D,Mackillop WJ.Prognostic factors in non-small cell lung cancer,a decade of progress[J].Chest,2002,122:1037-1057.
9Winton TL,Livingston R,Johnson D,et al.Vinorelbine plus Cisplatin vs.observation in resected non-small-cell lung cancer[J].N Engl J Med,2005,352:2589-2597.
10Douillard JY,Rosell R,Delena M,et al.ANITA:Phase Ⅲadjuvant vinorelbine and cisplatin versus observation in completely resected (stage Ⅰ -Ⅲ) non-small cell lung cancer patients:final results after 70-month median follow-up[J].J Clin Oncol,2005,23:Suppl 16S:624s.
3Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin, 2011, 61 (2) : 69-90.
4Dammers J, Spencer J, Thomas M. Using real patients in prob- lem-based learning: students comments on the value of using real, as opposed to paper, cases in a problem-based learning module in general practice. Med Edu, 2001, 35(1) : 27-34.
